These websites are presented as a service to Inhalation’s readers. Content is provided by the companies listed. No product endorsement or preference is intended.
WHITE PAPERS AND
WEBINARS
These technical articles and webinars are presented as a service to the
readers of Inhalation. Click on the link for access. Content is provided by the
companies listed. No product endorsement or preference is intended.
Copley Scientific
In this article, we review in vitro
methods used to assess nasal drug
product performance and the
role automation has in reducing
confounding variability.
https://www.copleyscientific.com
Proveris
'Proveris by Design™: A Roadmap
For in-vitro Characterization of
Combination Products' outlines a
proven testing strategy to accelerate
orally-inhaled and nasal drug product
development and describes novel
characterization techniques to
demonstrate better correlation to
clinical performance.
www.proveris.com
Catalent
In this article, Catalent experts
discuss intranasal drug product
development from formulation design
to manufacture and scale-up. Access
the article here:
https://www.catalent.com
Qualicaps
Qualicaps
®
inhalation portfolio
is the first range of capsules with
specific properties introduced in the
pharmaceutical marketplace. Research
and findings contribute to our
improved understanding of capsules
and DPIs' performance.
https://www.qualicaps.com
MKON
MKON's innovative ferrule design
reduces aluminum weight by 10% or
more, through pre-production scrap
generation, offering material cost
savings and sustainability.
www.mkonllc.com
Inhalation February 2023 35
Intertek
IVBE Particle Characterisation of
Generic Mometasone Furoate
using MDRS & Laser Diffraction.
Orthogonal methodologies to
assess API particles supporting
IVBE approaches for generic nasal
suspension products.
https://www.intertek.com
Renaissance
Nasal Spray R&D Services - With
our recently expanded R&D
Laboratory and cutting-edge spray
characterization instruments,
Renaissance is a "one-stop-shop" for
nasal spray formulation, development,
testing and commercialization.
https://www.renpharm.com
Recipharm
As sustainability and use of propellants
with low global warming potential
(GWP) become factors in pMDI
development, Recipharm explores
considerations for ensuring robust
clinical and commercial manufacturing
of next generation pMDIs.
https://www.recipharm.com
